As expected, tumor-bearing mice showed more frequent CD206+ macrophages in spleens than tumor-free mice, whereas PIR-B and PD-L1 blockade alone or in combination markedly decreased the frequency of CD206+ macrophages with the most apparent decrease in the combined blockade group (Figure 6F). Here, MRC1 is linked to neoplasm.